Related Experiment Video
Updated: Oct 4, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
Christian Mahnkopf1, Younghoon Kwon2, Nazem Akoum2
1Cardiology Department, Klinikim Coburg Coburg, Germany.
Insights
Atrial fibrosis, a key factor in atrial fibrillation (AF), increases stroke risk. This review explores the link between atrial disease, fibrosis, and stroke in AF and embolic stroke of undetermined source (ESUS) patients.
Area of Science:
- Cardiology
- Neurology
- Medical Imaging
Background:
- Atrial fibrosis is integral to the arrhythmic substrate in atrial fibrillation (AF).
- Atrial fibrosis is increasingly recognized as a contributor to stroke risk in AF patients.
- Embolic stroke of undetermined source (ESUS) patients often exhibit atrial fibrosis, suggesting a link to AF and recurrent stroke.
Purpose of the Study:
- To review the evidence connecting atrial disease and fibrosis with ischemic stroke risk in AF.
- To examine the association between atrial fibrosis and stroke in the ESUS population.
- To discuss implications for future research on stroke mechanisms and prevention in AF and ESUS.
Main Methods:
- Review of existing scientific literature and evidence.
- Analysis of studies measuring atrial fibrosis using late-gadolinium enhancement MRI.
- Examination of atrial remodeling encompassing structural, functional, and electrical properties.
Main Results:
- Atrial fibrosis is a significant factor in AF-related stroke.
- Atrial fibrosis is linked to recurrent stroke and new-onset AF in ESUS patients.
- Late-gadolinium enhancement MRI reveals atrial remodeling associated with fibrosis.
Conclusions:
- Atrial fibrosis is a critical link between AF and stroke risk.
- Understanding atrial fibrosis is crucial for stroke prevention strategies in AF and ESUS.
- Further research is needed to elucidate stroke mechanisms and refine prevention in these populations.
Abstract:
Atrial fibrosis is an important component of the arrhythmic substrate in AF. Evidence suggests that atrial fibrosis also plays a role in increasing the risk of stroke in patients with the arrhythmia. Patients with embolic stroke of undetermined source (ESUS), who are suspected to have AF but are rarely shown to have it, frequently demonstrate evidence of atrial fibrosis; measured using late-gadolinium enhancement MRI, this manifests as atrial remodelling encompassing structural, functional and electrical properties. In this review, the authors discuss the available evidence linking atrial disease, including fibrosis, with the risk of ischaemic stroke in AF, as well as in the ESUS population, in whom it has been linked to recurrent stroke and new-onset AF. They also discuss the implications of this association on future research that may elucidate the mechanism of stroke and stroke prevention strategies in the AF and ESUS populations.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Atherosclerosis IV: Nursing Management
Mitral Stenosis I: Introduction
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

